Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 9358285

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9346875

Therapy for filovirus infection

The United States of America as represented by the Secretary of the Army · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9315534

Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9290541

TCL1 peptides for immunotherapy

The Board of Regents of the University of Texas System · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9271985

Method of using vasoconstrictive agents during energy-based tissue therapy

Covidien LP · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9259452

Deacetylase inhibitor therapy

THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9233103

Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopi

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9211419

Treatments of disease or disorders using nanoparticles for focused hyperthermia to increas

The Board of Regents of the University of Texas System · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9198893

Combination antitumor therapy

Galera Labs, LLC · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9193701

Pyruvate kinase activators for use in therapy

Agios Pharmaceuticals, Inc. · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9180122

5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitor

Takeda Pharmaceutical Company Limited · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9180161

CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorder

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9176122

Biomarkers for predicting response to immunosuppressive therapy

United States Department of Veteran Affairs · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9168262

Estriol therapy for multiple sclerosis and other autoimmune diseases

The Regents of the University of California · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9161935

Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF the

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9125923

Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsivenes

The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9102752

Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

United Biomedical, Inc. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9095612

Halogenated compounds for photodynamic therapy

NANOQUANTUM SCIENCES, INC. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090589

Specific nNOS inhibitors for the therapy and prevention of human melanoma

The Regents of the University of California · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074185

Adoptive cell therapy with young T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066943

Use of botulinum toxin therapy for treatment of urological neurological conditions

The Regents of the University of Colorado · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040721

Halogenated compounds for Photodynamic therapy

NANOQUANTUM SCIENCES, INC. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034588

Monoclonal antibody therapy for pancreas cancer

PRECISION BIOLOGICS, INC. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8999290

Papillomavirus pseudoviruses for detection and therapy of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)